Cargando…
A4 PREDNISOLONE, A GLUCOCORTICOID WIDELY USED FOR TREATMENT OF IBD, ENHANCES A HUMAN INTERLEUKIN-4-ACTIVATED MACROPHAGE PHENOTYPE
BACKGROUND: With cellular immunotherapy, the individuals’ medication could ablate (or enhance) any therapeutic benefit of the transferred cells. Murine and human macrophages activated with IL-4 (i.e., M(IL4)) improve wound healing and reduce the severity of disease in murine models of colitis. Advan...
Autores principales: | Deshpande, R S, Callejas Pina, B E, Peng, R, Sousa, J A, Wang, A, Panaccione, R, McKay, D M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991387/ http://dx.doi.org/10.1093/jcag/gwac036.004 |
Ejemplares similares
-
Human interleukin-4–treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse model
por: Jayme, Timothy S., et al.
Publicado: (2020) -
The role of prednisolone in acute urticaria management
por: Godse, Kiran
Publicado: (2015) -
A196 CROHN’S DISEASE PATIENT DERIVED MACROPHAGES ARE MORE SUSCEPTIBLE TO HYDROGEN PEROXIDE INDUCED CELL DEATH
por: Sousa, J, et al.
Publicado: (2023) -
Interleukin-4 Programmed Macrophages Suppress Colitis and Do Not Enhance Infectious-Colitis, Inflammation-Associated Colon Cancer or Airway Hypersensitivity
por: Callejas, Blanca E., et al.
Publicado: (2021) -
A29 HIGH DIMENSIONAL SINGLE CELL ANALYSIS OF IL-4 TREATED MACROPHAGES REVEALS A HETEROGENIC PHENOTYPE AND THE ABSENCE OF CD206+ SUBSETS IN CROHN'S DISEASE PATIENTS
por: Callejas, B E, et al.
Publicado: (2023)